世界の非侵襲的出生前検査(NIPT)市場予測2023年-2028年

【英語タイトル】Non-Invasive Prenatal Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが出版した調査資料(IMARC23NOV225)・商品コード:IMARC23NOV225
・発行会社(調査会社):IMARC
・発行日:2023年10月
・ページ数:148
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算¥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

市場概要世界の非侵襲的出生前検査(NIPT)市場規模は2022年に34億米ドルに達しました。今後、IMARC Groupは、市場が2023年から2028年の間に17.2%の成長率(CAGR)を示し、2028年までに85億米ドルに達すると予測しています。

非侵襲的出生前検査(NIPT)は、胎児の異常の存在を検出するために妊婦の血液サンプルで実施される出生前スクリーニングの一形態です。この検査は主に、母親の血液中のDNA断片を分析することにより、ダウン症候群(またはトリソミー21)、エドワーズ症候群(またはトリソミー18)、パタウ症候群(またはトリソミー13)、ターナー症候群などの遺伝性疾患を診断するために用いられます。この方法は、絨毛膜絨毛サンプリング(CVS)のような様々な不安定で侵襲的な処置を必要とせず、妊娠9週以降に実施することができます。

胎児の遺伝性疾患の有病率の増加は、市場成長を促進する主な要因の一つです。さらに、ライフサイエンスとヘルスケア産業の分野における技術進歩も市場を後押ししています。例えば、DNAシークエンシング技術の開発、再生医療、分子研究の飛躍的進歩は、あらゆる重篤な疾患の可能性と原始的な段階で闘う計り知れない可能性を生み出しました。さらに、出生前検査の受け入れ率の増加、健康意識の高まり、大衆の間でこのような検査の利点と意義に関する認識も、市場の成長を促進しています。二分脊椎、口蓋裂、鎌状赤血球貧血を含む他の遺伝性疾患を診断し、胎児発育の初期段階で治療するための代替手段を、妊産婦だけでなく医療提供者も採用しています。さらに、母親の高年齢(35歳以上)での出産に向かう傾向の変化も、市場の成長にプラスの影響を与えています。母体年齢の上昇は、高血圧、生殖能力の低下、流産のリスク、胎児の染色体異常リスクの増加など、多くの健康合併症を引き起こす可能性があります。

主な市場セグメンテーション
IMARC Groupは、世界の非侵襲的出生前検査(NIPT)市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、製品タイプ、検査タイプ、技術、方法、用途、エンドユーザーに基づいて市場を分類しています。

製品タイプ別内訳
消耗品
器具

検査タイプ別内訳
マテルニ21
ハーモニー
パナロマ
ベリファイ
ニフティ
その他

技術別内訳
NGS
WGS
その他

方法別内訳
超音波検出
生化学的スクリーニング検査
母体血漿中無細胞DNA検査
母体血中胎児細胞検査
その他

アプリケーション別内訳
トリソミー
微小欠失症候群
その他

エンドユーザー別
病院
診断研究所
その他

地域別内訳
北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競争状況
本レポートでは、非侵襲的出生前検査(NIPT)の主要企業として、Agilent Technologies, Inc.、Berry Genetics, Inc.、BGI Genomics Co., Ltd.、Eurofins Scientific Services Limited、F. Hoffmann-La Roche Ltd.、GE Healthcare、Igenomix、Illumina Inc.、Laboratory Corporation、Natera Inc.、PerkinElmer Inc.、Thermo Fisher Scientific Inc.、Yourgene Health plcを挙げ、市場の競争環境についても分析しています。

本レポートで扱う主な質問
1. 2022年の世界の非侵襲的出生前検査(NIPT)市場規模は?
2. 2023〜2028年の世界の非侵襲的出生前検査(NIPT)市場の予想成長率は?
3. 世界の非侵襲的出生前検査(NIPT)市場を牽引する主要因は?
4. COVID-19が世界の非侵襲的出生前検査(NIPT)市場に与えた影響は?
5. 非侵襲的出生前検査(NIPT)の世界市場における製品タイプ別内訳は?
6. 検査タイプに基づく非侵襲的出生前検査(NIPT)の世界市場の内訳は?
7. 技術に基づく非侵襲的出生前検査(NIPT)の世界市場の内訳は?
8. 非侵襲的出生前検査(NIPT)の世界市場の手法別内訳は?
9. 非侵襲的出生前検査(NIPT)の世界市場の用途別内訳は?
10. エンドユーザーに基づく非侵襲的出生前検査(NIPT)の世界市場の内訳は?
11. 非侵襲的出生前検査(NIPT)の世界市場における主要地域は?
12. 非侵襲的出生前検査(NIPT)の世界市場における主要企業/プレーヤーは?

1 序論
2 範囲・方法
3 エグゼクティブサマリー
4 イントロダクション
5 非侵襲的出生前検査(NIPT)の世界市場
6 非侵襲的出生前検査(NIPT)の世界市場:製品タイプ別分析
7 非侵襲的出生前検査(NIPT)の世界市場:検査タイプ別分析
8 非侵襲的出生前検査(NIPT)の世界市場:技術別分析
9 非侵襲的出生前検査(NIPT)の世界市場:方法別分析
10 非侵襲的出生前検査(NIPT)の世界市場:用途別分析
11 非侵襲的出生前検査(NIPT)の世界市場:エンドユーザー別分析
12 非侵襲的出生前検査(NIPT)の世界市場:地域別分析
13 SWOT分析
14 バリューチェーン分析
15 ポーターズファイブフォース分析
16 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Non-Invasive Prenatal Testing Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Test Type
7.1 Materni 21
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Harmony
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Panaroma
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Verifi
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 NIFTY
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Others
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Technology
8.1 NGS
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 WGS
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Method
9.1 Ultrasound Detection
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Biochemical Screening Tests
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cell-Free DNA in Maternal Plasma Tests
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Fetal Cells in Maternal Blood Tests
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Application
10.1 Trisomy
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Microdeletion Syndrome
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by End-User
11.1 Hospitals
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Diagnostic Laboratories
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Others
11.3.1 Market Trends
11.3.2 Market Forecast
12 Market Breakup by Region
12.1 North America
12.1.1 United States
12.1.1.1 Market Trends
12.1.1.2 Market Forecast
12.1.2 Canada
12.1.2.1 Market Trends
12.1.2.2 Market Forecast
12.2 Asia Pacific
12.2.1 China
12.2.1.1 Market Trends
12.2.1.2 Market Forecast
12.2.2 Japan
12.2.2.1 Market Trends
12.2.2.2 Market Forecast
12.2.3 India
12.2.3.1 Market Trends
12.2.3.2 Market Forecast
12.2.4 South Korea
12.2.4.1 Market Trends
12.2.4.2 Market Forecast
12.2.5 Australia
12.2.5.1 Market Trends
12.2.5.2 Market Forecast
12.2.6 Indonesia
12.2.6.1 Market Trends
12.2.6.2 Market Forecast
12.2.7 Others
12.2.7.1 Market Trends
12.2.7.2 Market Forecast
12.3 Europe
12.3.1 Germany
12.3.1.1 Market Trends
12.3.1.2 Market Forecast
12.3.2 France
12.3.2.1 Market Trends
12.3.2.2 Market Forecast
12.3.3 United Kingdom
12.3.3.1 Market Trends
12.3.3.2 Market Forecast
12.3.4 Italy
12.3.4.1 Market Trends
12.3.4.2 Market Forecast
12.3.5 Spain
12.3.5.1 Market Trends
12.3.5.2 Market Forecast
12.3.6 Russia
12.3.6.1 Market Trends
12.3.6.2 Market Forecast
12.3.7 Others
12.3.7.1 Market Trends
12.3.7.2 Market Forecast
12.4 Latin America
12.4.1 Brazil
12.4.1.1 Market Trends
12.4.1.2 Market Forecast
12.4.2 Mexico
12.4.2.1 Market Trends
12.4.2.2 Market Forecast
12.4.3 Others
12.4.3.1 Market Trends
12.4.3.2 Market Forecast
12.5 Middle East and Africa
12.5.1 Market Trends
12.5.2 Market Breakup by Country
12.5.3 Market Forecast
13 SWOT Analysis
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 Value Chain Analysis
15 Porters Five Forces Analysis
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Agilent Technologies, Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Berry Genetics Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 BGI Genomics Co. Ltd.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Eurofins Scientific Services Limited
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.5 F. Hoffmann-La Roche Ltd
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 SWOT Analysis
16.3.6 GE Healthcare
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Igenomix
16.3.7.1 Company. Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.8 Illumina Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Laboratory Corporation
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Natera Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.11 Perkinelmer Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Thermo Fisher Scientific Inc.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 Yourgene Health plc
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials

Figure 1: Global: Non-Invasive Prenatal Testing Market: Major Drivers and Challenges
Figure 2: Global: Non-Invasive Prenatal Testing Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Non-Invasive Prenatal Testing Market: Breakup by Product Type (in %), 2022
Figure 4: Global: Non-Invasive Prenatal Testing Market: Breakup by Test Type (in %), 2022
Figure 5: Global: Non-Invasive Prenatal Testing Market: Breakup by Technology (in %), 2022
Figure 6: Global: Non-Invasive Prenatal Testing Market: Breakup by Method (in %), 2022
Figure 7: Global: Non-Invasive Prenatal Testing Market: Breakup by Application (in %), 2022
Figure 8: Global: Non-Invasive Prenatal Testing Market: Breakup by End-User (in %), 2022
Figure 9: Global: Non-Invasive Prenatal Testing Market: Breakup by Region (in %), 2022
Figure 10: Global: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 11: Global: Non-Invasive Prenatal Testing (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Non-Invasive Prenatal Testing (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Non-Invasive Prenatal Testing (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Non-Invasive Prenatal Testing (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Non-Invasive Prenatal Testing (Materni 21) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Non-Invasive Prenatal Testing (Materni 21) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Non-Invasive Prenatal Testing (Harmony) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Non-Invasive Prenatal Testing (Harmony) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Non-Invasive Prenatal Testing (Panaroma) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Non-Invasive Prenatal Testing (Panaroma) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Non-Invasive Prenatal Testing (Verifi) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Non-Invasive Prenatal Testing (Verifi) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Non-Invasive Prenatal Testing (NIFTY) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Non-Invasive Prenatal Testing (NIFTY) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Non-Invasive Prenatal Testing (NGS) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Non-Invasive Prenatal Testing (NGS) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Non-Invasive Prenatal Testing (WGS) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Non-Invasive Prenatal Testing (WGS) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Non-Invasive Prenatal Testing (Ultrasound Detection) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Non-Invasive Prenatal Testing (Biochemical Screening Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Non-Invasive Prenatal Testing (Cell-Free DNA in Maternal Plasma Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Non-Invasive Prenatal Testing (Fetal Cells in Maternal Blood Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: Non-Invasive Prenatal Testing (Trisomy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: Non-Invasive Prenatal Testing (Trisomy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Global: Non-Invasive Prenatal Testing (Microdeletion Syndrome) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Global: Non-Invasive Prenatal Testing (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Global: Non-Invasive Prenatal Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Global: Non-Invasive Prenatal Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Global: Non-Invasive Prenatal Testing (Others) Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Global: Non-Invasive Prenatal Testing (Others) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: North America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: North America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: United States: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: United States: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Canada: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Canada: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Asia Pacific: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Asia Pacific: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: China: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: China: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Japan: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Japan: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: India: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: India: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: South Korea: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: South Korea: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Australia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Australia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Indonesia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Indonesia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Europe: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Europe: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Germany: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Germany: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: France: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: France: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: United Kingdom: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: United Kingdom: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Italy: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Italy: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Spain: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Spain: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Russia: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Russia: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 93: Latin America: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 94: Latin America: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 95: Brazil: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 96: Brazil: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 97: Mexico: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 98: Mexico: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 99: Others: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 100: Others: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 101: Middle East and Africa: Non-Invasive Prenatal Testing Market: Sales Value (in Million US$), 2017 & 2022
Figure 102: Middle East and Africa: Non-Invasive Prenatal Testing Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 103: Global: Non-Invasive Prenatal Testing Industry: SWOT Analysis
Figure 104: Global: Non-Invasive Prenatal Testing Industry: Value Chain Analysis
Figure 105: Global: Non-Invasive Prenatal Testing Industry: Porter’s Five Forces Analysis

★調査レポート[世界の非侵襲的出生前検査(NIPT)市場予測2023年-2028年] (コード:IMARC23NOV225)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の非侵襲的出生前検査(NIPT)市場予測2023年-2028年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆